Kidney implications of SARS-CoV2 infection in children
- 28 August 2021
- journal article
- review article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 37 (7) , 1453-1467
Abstract
Research indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection can impact every organ, and the effects can range from asymptomatic to severe disease. Since it was first discovered in December 2019, our understanding has grown about its impact on kidney disease. In general, children have less severe disease than adults, and this tendency appears to extend to special pediatric kidney populations (e.g., chronic kidney disease and immunosuppressed patients with solid organ transplants or nephrotic syndrome). However, in a fraction of infected children, SARS-CoV2 causes an array of kidney manifestations, ranging from acute kidney injury to thrombotic microangiopathy, with potential implications for increased risk of morbidity and mortality. Additional considerations surround the propensity for clotting extracorporeal circuits in children with SARS-CoV2 infection that are receiving kidney replacement therapy. This review provides an update on our current understanding of SARS-CoV2 for pediatric nephrologists and highlights knowledge gaps to be addressed by future research during this ongoing pandemic, particularly the social disparities magnified during this period.Keywords
This publication has 91 references indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine, 2020
- Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 PandemicAmerican Journal of Kidney Diseases, 2020
- Covid-19 and Kidney TransplantationNew England Journal of Medicine, 2020
- Acute kidney injury in critically ill patients with COVID-19Intensive Care Medicine, 2020
- Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19Journal of the American Society of Nephrology, 2020
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysisIntensive Care Medicine, 2020
- Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centresNephrology Dialysis Transplantation, 2020
- Exploring racial influences on flu vaccine attitudes and behavior: Results of a national survey of White and African American adultsVaccine, 2017